Israel Englander’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.97M | Sell |
93,364
-471,056
| -83% | -$24.4M | ﹤0.01% | 2817 |
|
|
2026
Q1 | $27.2M | Sell |
564,420
-260,865
| -32% | -$11.6M | 0.01% | 1297 |
|
|
2025
Q4 | $34M | Sell |
825,285
-188,840
| -19% | -$7.58M | 0.01% | 1080 |
|
|
2025
Q3 | $39.4M | Sell |
1,014,125
-5,843
| -0.6% | -$190K | 0.02% | 1041 |
|
|
2025
Q2 | $28.2M | Buy |
1,019,968
+172,844
| +20% | +$4.4M | 0.01% | 1251 |
|
|
2025
Q1 | $18.8M | Buy |
847,124
+67,452
| +9% | +$1.39M | 0.01% | 1588 |
|
|
2024
Q4 | $15.4M | Buy |
779,672
+263,146
| +51% | +$6.01M | 0.01% | 1742 |
|
|
2024
Q3 | $12.9M | Sell |
516,526
-105,422
| -17% | -$2.57M | 0.01% | 1962 |
|
|
2024
Q2 | $11.6M | Buy |
621,948
+382,539
| +160% | +$7.17M | 0.01% | 1955 |
|
|
2024
Q1 | $4.72M | Sell |
239,409
-188,926
| -44% | -$3.69M | ﹤0.01% | 2918 |
|
|
2023
Q4 | $7.51M | Sell |
428,335
-177,239
| -29% | -$2.91M | ﹤0.01% | 2439 |
|
|
2023
Q3 | $10.5M | Buy |
605,574
+272,828
| +82% | +$4.6M | 0.01% | 2009 |
|
|
2023
Q2 | $4.69M | Sell |
332,746
-293,452
| -47% | -$3.93M | ﹤0.01% | 2737 |
|
|
2023
Q1 | $6.74M | Sell |
626,198
-144,452
| -19% | -$1.9M | ﹤0.01% | 2331 |
|
|
2022
Q4 | $11.5M | Sell |
770,650
-172,549
| -18% | -$2.51M | 0.01% | 1966 |
|
|
2022
Q3 | $12.1M | Buy |
943,199
+681,827
| +261% | +$7.77M | 0.01% | 1904 |
|
|
2022
Q2 | $2.53M | Sell |
261,372
-726,906
| -74% | -$6.78M | ﹤0.01% | 3459 |
|
|
2022
Q1 | $9.82M | Buy |
988,278
+460,475
| +87% | +$4.88M | 0.01% | 2192 |
|
|
2021
Q4 | $6.21M | Buy |
527,803
+300,288
| +132% | +$3.69M | ﹤0.01% | 2671 |
|
|
2021
Q3 | $2.59M | Sell |
227,515
-220,695
| -49% | -$2.87M | ﹤0.01% | 3607 |
|
|
2021
Q2 | $6.24M | Sell |
448,210
-24,426
| -5% | -$371K | ﹤0.01% | 2463 |
|
|
2021
Q1 | $8.75M | Buy |
472,636
+222,242
| +89% | +$4.55M | 0.01% | 1931 |
|
|
2020
Q4 | $4.42M | Sell |
250,394
-102,635
| -29% | -$1.8M | ﹤0.01% | 2562 |
|
|
2020
Q3 | $5.41K | Buy |
353,029
+130,783
| +59% | +$2.46M | 0.01% | 1770 |
|
|
2020
Q2 | $5.66M | Buy |
222,246
+42,617
| +24% | +$890K | 0.01% | 1648 |
|
|
2020
Q1 | $2.78M | Sell |
179,629
-29,792
| -14% | -$466K | 0.01% | 1776 |
|
|
2019
Q4 | $2.32M | Buy |
+209,421
| New | +$1.82M | ﹤0.01% | 2520 |
|
|
2019
Q2 | – | Sell |
-31,070
| Closed | -$561K | – | 4272 |
|
|
2019
Q1 | $561K | Sell |
31,070
-75,336
| -71% | -$1.46M | ﹤0.01% | 3195 |
|
|
2018
Q4 | $2.99M | Sell |
106,406
-115,644
| -52% | -$2.41M | ﹤0.01% | 1952 |
|
|
2018
Q3 | $5.66M | Buy |
222,050
+199,631
| +890% | +$3.88M | 0.01% | 1708 |
|
|
2018
Q2 | $389K | Buy |
+22,419
| New | +$406K | ﹤0.01% | 3277 |
|
Other funds holding KNSA
RCMNY
BBA
TCM
SSC
Israel Englander's KNSA Position: Q2 2026 in Review
Israel Englander reduced its Kiniksa Pharmaceuticals (KNSA) stake by 83% in Q2 2026, selling an estimated $24.4M and leaving 93,364 shares worth $5.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2817.
Israel Englander first reported a position in KNSA in Q2 2018 and has held it in 31 quarters since. The position peaked at $39.4M in Q3 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.
- Israel Englander held 93,364 shares of Kiniksa Pharmaceuticals worth $5.97M as of Q2 2026.
- Israel Englander sold 471,056 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $24.4M.
- Kiniksa Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2817 holding.
- Israel Englander first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and has held it in 31 quarters since.
- Israel Englander's Kiniksa Pharmaceuticals position peaked at $39.4M in Q3 2025.
- 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.